Abstract
No public abstract is available from the verified source records.
Hussein Zaitoon
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
10.1056/nejmoa1902226 · 2019
Teplizumab and β-cell function in newly diagnosed type 1 diabetes
10.1056/nejmoa2308743 · 2023
Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes
10.1007/s00125-025-06586-1 · 2026
Automated insulin delivery systems and glucose management in children and adolescents with type 1 diabetes: a systematic review and meta-analysis
10.1001/jamapediatrics.2025.2740 · 2025
Stem cell-derived, fully differentiated islets for type 1 diabetes
10.1056/nejmoa2506549 · 2025
No additional external references are available.